Past, Present and Future for Developing Clinical Trials in Bulgaria
Bulgaria is the 14th largest country in Europe in terms of surface area (110,994 km2) and is located between Romania to the North, Serbia and Macedonia to the West, Greece and Turkey to the South and the Black Sea to the East. It has a population of 7,364,570. Cristina Florescu Moraid and Aneta Ivanova of Synevo Central Lab, along with Georgi Georgiev AstraZeneca-Bulgari, demonstrate that the development of clinical trials in this country is very promising: the existing legislative framework is suitable for any pharmaceutical company to direct its actions to Bulgarian patients, and the fact that Bulgaria is among the European emerging countries has to be seriously taken into account.
http://jforcs.com/jcs/wp-content/uploads/2013/04/Past-Present-and-Future-for-Developing-Clinical-Trials-in-Bulgaria.pdf